Author: Melanie De Almeida
Former journalist intern. Melanie has studied in Germany and Denmark and did an internship at Novo Nordisk, where she had a glimpse to the workings of pharma. She is now a Ph.D. student at the IMP in Vienna.
Taking Biotech to the Next Level with Laboratory Automation
French Biotech Takes its Oral Diabetes Drug to Phase III
CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine
Update: Potential Breakthrough Treatment for Deadly Lung Disease Starts Phase IIb
Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links
Regenerating the Body With Stem Cells – Hype or Hope?
This Danish Biotech Thinks it Can Tackle the Obesity Epidemic
New Drug for Neuropathic Pain Is Forging its Way through the Clinic
Video: The Next Big Thing in Biotech according to Sofinnova’s Antoine Papiernik
